Quality indicators for depression treatment in primary care: A systematic literature review

Current Psychiatry Reviews

Volumn 7, Issue 2, 2011, Pages 104-137

  Duhoux, Arnaud ^a,b,c   Fournier, Louise ^a,b,c   Menear, Matthew ^a,b,c  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

Author keywords

Adequacy of treatment; Clinical guideline; Depression; Primary care; Quality indicator; Quality of care

Indexed keywords

ANTIDEPRESSANT AGENT;

DEPRESSION; EMBASE; FOLLOW UP; HEALTH CARE QUALITY; HUMAN; MEDLINE; METHODOLOGY; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; PSYCINFO; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION;

EID: 79960612904     PISSN: 15734005     EISSN: 18756441     Source Type: Journal    
DOI: 10.2174/157340011796391166     Document Type: Review

References (142)

1. Kessler RC, Nelson CB, McGonagle KA, et al. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatr Suppl 1996; (30): 17-30.
2. Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. Global burden of depressive disorders in the year 2000. Br J Psychiatr 2004; 184: 386-92.
3. Patten SB, Kennedy SH, Lam RW, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management. J Affect Disord 2009; 117(Suppl 1): S5-14.
4. WHO. The world health report 2001 - Mental Health: New Understanding, New Hope. Geneva: World Health Organization. 172. 2001.
5. Wang PS, Aguilar-Gaxiola S, Alonso J, et al. Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet 2007; 370(9590): 841-50.
6. Pincus HA, Pechura CM, Elinson L, Pettit AR. Depression in primary care: linking clinical and systems strategies. Gen Hosp Psychiatr 2001; 23(6): 311-8.
7. Gilbody SM, Whitty PM, Grimshaw JM, Thomas RE. Improving the detection and management of depression in primary care. Qual Saf Health Care 2003; 12(2): 149-55.
8. Duhoux A, Fournier L, Nguyen CT, Roberge P, Beveridge R. Guideline concordance of treatment for depressive disorders in Canada. Soc Psychiatr Psychiatr Epidemiol 2009; 44(5): 385-92.
9. Wells KB, Sherbourne C, Schoenbaum M, et al. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. Jama 2000; 283(2): 212-20.
10. Asarnow JR, Jaycox LH, Duan N, et al. Effectiveness of a quality improvement intervention for adolescent depression in primary care clinics: a randomized controlled trial. Jama 2005; 293(3): 311-9.
11. Hepner KA, Rowe M, Rost K, et al. The effect of adherence to practice guidelines on depression outcomes. Ann Intern Med 2007; 147(5): 320-9.
12. Rost K, Williams C, Wherry J, Smith GR Jr. The process and outcomes of care for major depression in rural family practice settings. J Rural Health 1995; 11(2): 114-21.
13. Sturm R, Wells KB. How can care for depression become more cost-effective? Jama 1995; 273(1): 51-8.
14. Melfi CA, Chawla AJ, Croghan TW, et al. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatr 1998; 55(12): 1128-32.
15. Sood N, Treglia M, Obenchain RL, et al. Determinants of antidepressant treatment outcome. Am J Manag Care 2000; 6(12): 1327-36.
16. Pyne JM, Rost KM, Zhang M, et al. Cost-effectiveness of a primary care depression intervention. J Gen Intern Med 2003; 18(6): 432-41.
17. American Psychiatric Association. Practice guideline for major depressive disorder in adults. Am J Psychiatr 1993; 150(4 Suppl): 1-26.
18. Agency for health care Policy and Research - US Dept of health and human services Agency. Depression in primary care. In Vol 2: Treatment of major depression. Rockville, Md. 1993.
19. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatr 2000; 157(4 Suppl): 1-45.
20. [Canadian Psychiatric Association; Canadian Network for Mood and Anxiety Treatments (CANMAT). Clinical guidelines for the treatment of depressive disorders. Can J Psychiatr 2001; 46(Suppl 1): 5S-90S.
21. Ellis P. Australian and New Zealand clinical practice guidelines for the treatment of depression. Aust N Z J Psychiatr 2004; 38(6): 389-407.
22. Brugha TS, Lindsay F. Quality of mental health service care: the forgotten pathway from process to outcome. Soc Psychiatry Psychiatr Epidemiol 1996; 31(2): 89-98.
23. Tugwell P. A methodological perspective on process measures of the quality of medical care. Clin Invest Med 1979; 2(2-3): 113-21.
24. Donabedian A. Evaluating the quality of medical care. Milbank Mem Fund Q 1966; 44(Suppl 3): 166-206.
25. Charbonneau A, Rosen AK, Owen RR, et al. Monitoring depression care: in search of an accurate quality indicator. Med Care 2004; 42(6): 522-31.
26. Micossi P, Carbone M, Stancanelli G, Fortino A. Measuring products of healthcare systems. Lancet 1993; 341(8860): 1566-7.
27. Hermann RC, Palmer RH. Common ground: a framework for selecting core quality measures for mental health and substance abuse care. Psychiatr Serv 2002; 53(3): 281-7.
28. ®. Proquest [homepage on the Internet] updated 2010; Available from: http://www.serialssolutions.com/360-search/.
29. Asch SM, McGlynn EA, Hogan MM, et al. Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample. Ann Intern Med 2004; 141(12): 938-45.
30. Katz, SJ, Kessler RC, Lin E, Wells KB. Medication management of depression in the United States and Ontario. J Gen Intern Med, 1998. 13(2): 77-85.
31. Olfson, M, Marcus SC, Druss B, et al. National trends in the outpatient treatment of depression. Jama, 2002. 287(2): 203-9.
32. Harman, JS, Edlund MJ, Fortney JC. Disparities in the adequacy of depression treatment in the United States. Psychiatr Serv, 2004. 55(12): 1379-85.
33. Kendrick, T, Dowrick C, McBride A, et al. Management of depression in UK general practice in relation to scores on depression severity questionnaires: analysis of medical record data. Bmj, 2009. 338: b750.
34. Gill, JM, Chen YX, Lieberman MI. Management of depression in ambulatory care for patients with medical co-morbidities: a study from a national Electronic Health Record (EHR) network. Int J Psychiatry Med, 2008. 38(2): 203-15.
35. Wittchen, HU, Hofler M, Meister W. Prevalence and recognition of depressive syndromes in German primary care settings: poorly recognized and treated? Int Clin Psychopharmacol, 2001. 16(3): 121-35.
36. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association 1994.
37. World Health Organization. International Classification of Diseases, 10th Revision (ICD-10). Geneva, Switzerland: World Health Organization 1992.
38. [Schneider, F, Kratz S, Bermejo I, et al. Insufficient depression treatment in outpatient settings. Ger Med Sci, 2004; 2: Doc01.
39. Wells, KB, Schoenbaum M, Unutzer J, Lagomasino IT, Rubenstein LV. Quality of care for primary care patients with depression in managed care. Arch Fam Med, 1999; 8(6): 529-36.
40. Sewitch, MJ, Blais R, Rahme E, Bexton B, Galarneau S. Receiving guideline-concordant pharmacotherapy for major depression: impact on ambulatory and inpatient health service use. Can J Psychiatry, 2007; 52(3): 191-200.
41. Pinto-Meza, A, Fernandez A, Serrano-Blanco A, Haro JM. Adequacy of antidepressant treatment in Spanish primary care: a naturalistic six-month follow-up study. Psychiatr Serv, 2008; 59(1): 78-83.
42. Charbonneau, A, Rosen AK, Ash AS, et al. Measuring the quality of depression care in a large integrated health system. Med Care, 2003; 41(5): 669-80.
43. Spettell, CM, Wall TC, Allison J, et al. Identifying physicianrecognized depression from administrative data: consequences for quality measurement. Health Serv Res, 2003; 38(4): 1081-102.
44. Joo, JH, Solano FX, Mulsant BH, Reynolds CF, Lenze EJ. Predictors of adequacy of depression management in the primary care setting. Psychiatr Serv, 2005; 56(12): 1524-8.
45. Baker, R, Reddish S, Robertson N, Hearnshaw H, Jones B. Randomised controlled trial of tailored strategies to implement guidelines for the management of patients with depression in general practice. Br J Gen Pract, 2001; 51(470): 737-41.
46. [Donoghue, JM, Tylee A. The treatment of depression: prescribing patterns of antidepressants in primary care in the UK. Br J Psychiatry, 1996.;168(2): 164-8.
47. Saunders, K, Simon G, Bush T, Grothaus L. Assessing the feasibility of using computerized pharmacy refill data to monitor antidepressant treatment on a population basis: a comparison of automated and self-report data. J Clin Epidemiol, 1998; 51(10): 883-90.
48. Herique, A, Kahn JP. Guidelines and reality in practical use of and compliance to antidepressants in the treatment of depression: incidence survey in Lorraine and Champagne-Ardenne (France). Encephale, 2009; 35(1): 73-9.
49. Balestrieri, M, Carta MG, Leonetti S, et al. Recognition of depression and appropriateness of antidepressant treatment in Italian primary care. Soc Psychiatry Psychiatr Epidemiol, 2004; 39(3): 171-6.
50. Busch, SH, Leslie D, Rosenheck R. Measuring quality of pharmacotherapy for depression in a national health care system. Med Care, 2004; 42(6): 532-42.
51. Solberg, LI, Crain AL, Sperl-Hillen JM, et al. Effect of improved primary care access on quality of depression care. Ann Fam Med, 2006; 4(1): 69-74.
52. Katon, W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. Jama, 1995; 273(13): 1026-31.
53. Katon, WJ, Simon G, Russo J, et al. Quality of depression care in a population-based sample of patients with diabetes and major depression. Med Care, 2004; 42(12): 1222-9.
54. Simon, GE, Von Korff M, Rutter CM, Peterson DA. Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians. Arch Gen Psychiatry, 2001; 58(4): 395-401.
55. Dobscha, SK, Gerrity MS, Corson K, Bahr A, Cuilwik NM. Measuring adherence to depression treatment guidelines in a VA primary care clinic. Gen Hosp Psychiatry, 2003; 25(4): 230-7.
56. Cully, JA, Zimmer M, Khan MM, Petersen LA. Quality of depression care and its impact on health service use and mortality among veterans. Psychiatr Serv, 2008; 59(12): 1399-405.
57. Dickinson, LM, Dickinson WP, Rost K, et al. Clinician burden and depression treatment: disentangling patient-and clinician-level effects of medical comorbidity. J Gen Intern Med, 2008; 23(11): 1763-9.
58. Katon, W, Rutter CM, Lin E, et al. Are there detectable differences in quality of care or outcome of depression across primary care providers? Med Care, 2000; 38(6): 552-61.
59. Gonzalez, HM, Vega WA, Williams DR, et al. Depression care in the United States: too little for too few. Arch Gen Psychiatry, 2010; 67(1): 37-46.
60. Rost, K, Fortney J, Coyne J. The relationship of depression treatment quality indicators to employee absenteeism. Ment Health Serv Res, 2005; 7(3): 161-9.
61. Rollman, BL, Hanusa BH, Lowe HJ, et al. A randomized trial using computerized decision support to improve treatment of major depression in primary care. J Gen Intern Med, 2002; 17(7): 493-503.
62. Starkes, JM, Poulin CC, Kisely SR. Unmet need for the treatment of depression in Atlantic Canada. Can J Psychiatry, 2005; 50(10): 580-90.
63. Young, AS, Klap R, Sherbourne CD, Wells KB. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry, 2001; 58(1): 55-61.
64. Diverty, B, Beaudet MP. La dépression: un trouble partiellement traité? Rapports sur la santé, 1997; 8(4): 9-19.
65. Clever, SL, Ford DE, Rubenstein LV, et al. Primary care patients' involvement in decision-making is associated with improvement in depression. Med Care, 2006; 44(5): 398-405.
66. Chermack, ST, Zivin K, Valenstein M, et al. The prevalence and predictors of mental health treatment services in a national sample of depressed veterans. Med Care, 2008; 46(8): 813-20.
67. Esposito, E, Wang JL, Adair CE, et al. Frequency and adequacy of depression treatment in a Canadian population sample. Can J Psychiatry, 2007; 52(12): 780-9.
68. Teh, CF, Reynolds CF, 3rd, Cleary PD. Quality of depression care for people with coincident chronic medical conditions. Gen Hosp Psychiatry, 2008; 30(6): 528-35.
69. Nutting, PA, Rost K, Smith J, Werner JJ, Elliot C. Competing demands from physical problems: effect on initiating and completing depression care over 6 months. Arch Fam Med, 2000; 9(10): 1059-64.
70. Gandjour, A, Telzerow A, Lauterbach KW. Costs and quality in the treatment of acute depression in primary care: a comparison between England, Germany and Switzerland. Int Clin Psychopharmacol, 2004; 19(4): 201-8.
71. Busch, SH. Specialty health care, treatment patterns, and quality: the impact of a mental health carve-out on care for depression. Health Serv Res, 2002; 37(6): 1583-601.
72. Kniesner, TJ, Powers RH, Croghan TW. Provider type and depression treatment adequacy. Health Policy, 2005; 72(3): 321-32.
73. Fernandez, A, Haro JM, Martinez-Alonso M, et al. Treatment adequacy for anxiety and depressive disorders in six European countries. Br J Psychiatry, 2007; 190: 172-3.
74. Fernandez, A, Haro JM, Codony M, et al. Treatment adequacy of anxiety and depressive disorders: primary versus specialised care in Spain. J Affect Disord, 2006; 96(1-2): 9-20.
75. Wang, PS, Lane M, Olfson M, et al. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry, 2005; 62(6): 629-40.
76. Meredith, LS, Orlando M, Humphrey N, Camp P, Sherbourne CD. Are better ratings of the patient-provider relationship associated with higher quality care for depression? Med Care, 2001; 39(4): 349-60.
77. Rubenstein, LV, Meredith LS, Parker LE, et al. Impacts of evidence-based quality improvement on depression in primary care: a randomized experiment. J Gen Intern Med, 2006; 21(10): 1027-35.
78. Henke, RM, McGuire TG, Zaslavsky AM, et al. Clinician-and organization-level factors in the adoption of evidence-based care for depression in primary care. Health Care Manage Rev, 2008; 33(4): 289-99.
79. Smolders, M, Laurant M, Roberge P, et al. How well do GPs fulfill their educator role in consultations for depression and anxiety? Patient Educ Couns, 2008; 73(2): 389-95.
80. Robins, LN, Wing J, Wittchen HU, et al. The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry, 1988; 45(12): 1069-77.
81. Wang, PS, Berglund P, Kessler RC. Recent care of common mental disorders in the United States: prevalence and conformance with evidence-based recommendations. J Gen Intern Med, 2000; 15(5): 284-92.
82. Kessler, RC, Andrews G, Mroczek D, Ustun TB, Wittchen H-U. The World Health Organization Composite International Diagnostic Interview Short Form (CIDI-SF). International Journal of Methods in Psychiatric Research, 1998; 7(4): 171-185.
83. Patten, SB. Performance of the Composite International Diagnostic Interview Short Form for major depression in community and clinical samples. Chronic Dis Can, 1997; 18(3): 109-12.
84. Grolleau, A, Cougnard A, Begaud B, Verdoux H. Congruence between diagnosis of recurrent major depressive disorder and psychotropic treatment in the general population. Acta Psychiatr Scand, 2008; 117(1): 20-7.
85. Lecrubier, Y, Sheehan DV, Weiller E, et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. European Psychiatry, 1997; 12(5): 224-231.
86. Gruenberg, AM, Goldstein RD, Pincus HA, et al. Classification of depression: research and diagnostic criteria: DSM-IV and ICD-10. In Biology of depression. From novel insights to therapeutic strategies. Weinheim: Ed. Licinio J, Wong M-L. Wiley-VCH Verlag GmbH & Co. 2005.
87. Hemels, ME, Koren G, Einarson TR. Increased use of antidepressants in Canada: 1981-2000. Ann Pharmacother, 2002; 36(9): 1375-9.
88. Olfson, M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry, 2009; 66(8): 848-56.
89. Beck, CA, Patten SB, Williams JV, et al. Antidepressant utilization in Canada. Soc Psychiatry Psychiatr Epidemiol, 2005; 40(10): 799-807.
90. Katon, WJ, Seelig M. Population-based care of depression: team care approaches to improving outcomes. J Occup Environ Med, 2008; 50(4): 459-67.
91. National Institute for Clinical Excellence. Depression: Management of Depression in Primary and Secondary Care. Clinical Guideline 23. London: NICE 2004.
92. Andrews, G. Should depression be managed as a chronic disease? Bmj, 2001. 322(7283): 419-21.
93. Kwon, A, Bungay KM, Pei Y, et al. Antidepressant use: concordance between self-report and claims records. Med Care, 2003; 41(3): 368-74.
94. Rhodes, AE, Lin E, Mustard CA. Self-reported use of mental health services versus administrative records: should we care? Int J Methods Psychiatr Res, 2002; 11(3): 125-33.
95. Chen, RS, Rosenheck R. Using a computerized patient database to evaluate guideline adherence and measure patterns of care for major depression. J Behav Health Serv Res, 2001; 28(4): 466-74.
96. Cornwall, PL, Scott J. Which clinical practice guidelines for depression? An overview for busy practitioners. Br J Gen Pract, 2000. 50(460): p. 908-11.
97. Peveler, R, Kendrick T. Treatment delivery and guidelines in primary care. Br Med Bull, 2001; 57: 193-206.
98. Hickie, IB. Primary care psychiatry is not specialist psychiatry in general practice. Med J Aust, 1999; 170(4): 171-3.
99. Fortin, M, Dionne J, Pinho G, et al. Randomized controlled trials: do they have external validity for patients with multiple comorbidities? Ann Fam Med, 2006; 4(2): 104-8.
100. Rothwell, PM. External validity of randomised controlled trials: to whom do the results of this trial apply?. Lancet, 2005; 365(9453): 82-93.
101. Heath, I, Rubinstein A, Stange KC, van Driel ML. Quality in primary health care: a multidimensional approach to complexity. Bmj, 2009; 338: b1242.
102. Campbell, SM, Shield T, Rogers A, Gask L. How do stakeholder groups vary in a Delphi technique about primary mental health care and what factors influence their ratings? Qual Saf Health Care, 2004; 13(6): 428-34.
103. Stange, KC. The paradox of the parts and the whole in understanding and improving general practice. Int J Qual Health Care, 2002; 14(4): 267-8.
104. Shield, T, Campbell S, Rogers A, et al. Quality indicators for primary care mental health services. Qual Saf Health Care, 2003; 12(2): 100-6.
105. Schoen, C, Osborn R, Huynh PT, et al. On the front lines of care: primary care doctors' office systems, experiences, and views in seven countries. Health Aff (Millwood), 2006; 25(6): w555-71.
106. Hurtado, MP, Swift EK, Corrigan JM. Committee on the National Quality Report on Health Care Delivery, Board on Health Care Services. Envisioning the National Health Care Quality Report. Washington, DC: National Academies Press. 2001.
107. Ma, J, Stafford RS. Quality of US outpatient care: temporal changes and racial/ethnic disparities. Arch Intern Med, 2005; 165(12): 1354-61.
108. Fauman, MA. Quality assurance monitoring in psychiatry. Am J Psychiatry, 1989. 146(9): p. 1121-30.
109. [Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument. Available from: www.agreecollaboration.org.
110. Berwick, DM, James B, Coye MJ. Connections between quality measurement and improvement. Med Care, 2003; 41(1 Suppl): I30-8.
111. Alegria, M, Frank R, McGuire T. Managed care and systems costeffectiveness: treatment for depression. Med Care, 2005; 43(12): 1225-33.
112. Harman, JS, Edlund MJ, Fortney JC. Trends in antidepressant utilization from 2001 to 2004. Psychiatr Serv, 2009; 60(5): 611-6.
113. Unutzer, J, Rubenstein L, Katon WJ, et al. Two-year effects of quality improvement programs on medication management for depression. Arch Gen Psychiatry, 2001; 58(10): 935-42.
114. Stokes, PE. A primary care perspective on management of acute and long-term depression. J Clin Psychiatry, 1995; 13(2): 23-33.
115. Reesal, R, Vincent P. Depression: Diagnosis and Treatment in Primary Care. Toronto: Association médicale du Canada 1992.
116. Guidelines Advisory Committee. Outpatient Management of Depression. Toronto: Centre for Effective Practice 2001.
117. Agence nationale d'accréditation de d'évaluation en santé. Prise en charge d'un épisode dépressif isolé de l'adulte en ambulatoire. Paris: Agence nationale d'accréditation de d'évaluation en santé 2002.
118. Agence française de sécurité sanitaire des produits de santé. Bon usage des médicaments antidépresseurs dans le traitement des troubles dépressifs et des troubles anxieux de l'adulte. Recommandations. Paris: Agence française de sécurité sanitaire des produits de santé 2006.
119. Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry, 1960; 23: 56-62.
120. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Service, US Dept of Health and Human Services 1988.
121. Zimmerman, M, Coryell W, Corenthal C, Wilson S. A self-report scale to diagnose major depressive disorder. Arch Gen Psychiatry, 1986; 43(11): 1076-81.
122. Wittchen, H-U, Pfister H. DIA-X-Interviews: Manual fur Screening- Verfahren und Interview; Interviewheft Langsschnittuntersuchung (DIA-X-Lifetime); Erganzungsheft (DIA-X-Lifetime); Interviewheft Querschnittuntersuchung (DIA-X-12 Monate); Erganzungsheft (DIA-X-12Monate); PC-Programm zur Durchfuhrung des Interviews (Langs-und Querschnit-tuntersuchung); Auswertungsprogramm. Frankfurt: Swets & Zeitlinger 1997.
123. Dunn, RL, Donoghue JM, Ozminkowski RJ, Stephenson D, Hylan TR. Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines. J Psychopharmacol, 1999; 13(2): 136-43.
124. Paykel, ES, Priest RG. Recognition and management of depression in general practice: consensus statement. Bmj, 1992; 305(6863): 1198-202.
125. Freemantle, N, Song F, Sheldon TA, et al. Managing depression in primary care. Qual Health Care, 1993; 2(1): 58-62.
126. The Management of Major Depressive Disorder Working Group. Veterans Health Administration/Department of Defense clinical practice guideline for the management of major depressive disorder in adults. Version 2.0. Washington, DC: Veterans Health Administration 2000.
127. British Association for Psychopharmacology. Guidelines for treating depressive illness with antidepressants. Journal of Psychopharmacology, 1993; 7: 19-23.
128. Kroenke, K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med, 2001; 16(9): 606-13.
129. Zigmond, AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand, 1983; 67(6): 361-70.
130. Spitzer, RL, Williams JB, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIMEMD 1000 study. Jama, 1994; 272(22): 1749-56.
131. Katon, W, von Korff M, Lin E, Bush T, Ormel J. Adequacy and duration of antidepressant treatment in primary care. Med Care, 1992; 30(1): 67-76.
132. Department of Veterans Affairs. Clinical Practice Guidelines for Major Depressive Disorder. Washington, DC: Department of Veterans Affairs 1997.
133. Agency for Health Care Policy and Research. Treatment of Depression: New Pharmacotherapies. Rockville, MD: US Department of Health and Human Services 1999.
134. Klein DF, Gittelman R, Quitkin F, et al. Diagnosis and Drug Treatment of Psychiatric Disorders: Adults and Children. 2nd ed. Baltimore: Williams and Wilkens 1980.
135. Baldesserini RJ. Chemotherapy in Psychiatry. Cambridge, MA: Harvard University Press 1977.
136. Robins, LN, Helzer JE, Croughan J, Ratcliff KS. National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Arch Gen Psychiatry, 1981; 38(4): 381-9.
137. Gandjour, A, Kleinschmit F, Littmann V, Lauterbach KW. An evidence-based evaluation of quality and efficiency indicators. Qual Manag Health Care, 2002; 10(4): 41-52.
138. van Marwijk, HWJ, Grundmeijer HGLM, Bijl D, et al. Guideline Depressive Disorder. Dutch College of General Practitioners (first revision). Huisarts en Wetenschap, 2003; 46: 614-23.
139. Fortney, J, Rost K, Zhang M, Pyne J. The relationship between quality and outcomes in routine depression care. Psychiatr Serv 2001; 52(1): 56-62.
140. Schulberg, HC, Block MR, Madonia MJ, et al. The 'usual care' of major depression in primary care practice. Arch Fam Med 1997; 6(4):334-9.
141. Smolders, M, Laurant M, Verhaak P, et al. Adherence to evidencebased guidelines for depression and anxiety disorders is associated with recording of the diagnosis. Gen Hosp Psychiatry 2009; 31(5):460-9.
142. Burnam, MA, Wells KB, Leake B, Landsverk J. Development of a brief screening instrument for detecting depressive disorders. Med Care 1988; 26(8): 775-89.